Petra van der Groep
Overview
Explore the profile of Petra van der Groep including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1744
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Jonge L, Toes-Zoutendijk E, Koopmann B, van Schrojenstein Lantman M, Franken-van Vorsselen B, Speijers C, et al.
Clin Chim Acta
. 2024 Jun;
561:119809.
PMID: 38879061
Background: As the impact of unmanaged bias (i.e. systematic source of inaccuracy) in fecal immunochemical test (FIT) analytical performance on long-term colorectal cancer (CRC) outcomes is unknown, we assessed the...
2.
Moelans C, de Ligt J, van der Groep P, Prins P, Besselink N, Hoogstraat M, et al.
Endocr Relat Cancer
. 2019 Jul;
26(10):779-794.
PMID: 31340200
Male breast cancer (MBC) is extremely rare and accounts for less than 1% of all breast malignancies. Therefore, clinical management of MBC is currently guided by research on the disease...
3.
Vos S, Elias S, van der Groep P, Smolders Y, van Gils C, van Diest P
Am J Surg Pathol
. 2018 Jul;
42(9):1262-1272.
PMID: 29979200
Heredity, mostly due to BRCA germline mutations, is involved in 5% to 10% of all breast cancer cases. Potential BRCA germline mutation carriers may be missed following the current eligibility...
4.
Severson T, Kim Y, Joosten S, Schuurman K, van der Groep P, Moelans C, et al.
Nat Commun
. 2018 Feb;
9(1):482.
PMID: 29396493
Male breast cancer (MBC) is rare and poorly characterized. Like the female counterpart, most MBCs are hormonally driven, but relapse after hormonal treatment is also noted. The pan-hormonal action of...
5.
Lodewijk L, van Diest P, van der Groep P, Ter Hoeve N, Schepers A, Morreau J, et al.
Oncotarget
. 2017 Apr;
8(17):28650-28659.
PMID: 28404916
Background: Medullary thyroid cancer (MTC) comprises only 4% of all thyroid cancers and originates from the parafollicular C-cells. HIF-1α expression has been implied as an indicator of worse prognosis in...
6.
Warmoes M, Lam S, van der Groep P, Jaspers J, Smolders Y, de Boer L, et al.
Oncotarget
. 2016 Aug;
7(39):63537-63548.
PMID: 27566577
Breast cancer arising in female BRCA1 mutation carriers is characterized by an aggressive phenotype and early age of onset. We performed tandem mass spectrometry-based proteomics of secretomes and exosome-like extracellular...
7.
Schrijver W, van der Groep P, Hoefnagel L, Ter Hoeve N, Peeters T, Moelans C, et al.
Mod Pathol
. 2016 Aug;
29(12):1460-1470.
PMID: 27562496
Distant breast cancer metastases are nowadays routinely biopsied to reassess receptor status and to isolate DNA for sequencing of druggable targets. Bone metastases are the most frequent subgroup. Decalcification procedures...
8.
Tenhagen M, Klarenbeek S, Braumuller T, Hofmann I, van der Groep P, Ter Hoeve N, et al.
J Mammary Gland Biol Neoplasia
. 2016 Jul;
21(3-4):81-88.
PMID: 27411687
Loss of E-cadherin expression is causal to the development of invasive lobular breast carcinoma (ILC). E-cadherin loss leads to dismantling of the adherens junction and subsequent translocation of p120-catenin (p120)...
9.
Varier R, Carrillo De Santa Pau E, van der Groep P, Lindeboom R, Matarese F, Mensinga A, et al.
J Biol Chem
. 2016 Feb;
291(14):7313-24.
PMID: 26841866
Recent work from others and us revealed interactions between the Sin3/HDAC complex, the H3K4me3 demethylase KDM5A, GATAD1, and EMSY. Here, we characterize the EMSY/KDM5A/SIN3B complex in detail by quantitative interaction...
10.
Vos S, Vesuna F, Raman V, van Diest P, van der Groep P
Oncotarget
. 2015 Sep;
6(31):32115-37.
PMID: 26378051
miRNA deregulation has been found to promote carcinogenesis. Little is known about miRNA deregulation in hereditary breast tumors as no miRNA expression profiling studies have been performed in normal breast...